SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $66,000 | -55.1% | 53,066 | -90.5% | 0.00% | -100.0% |
| Q2 2020 | $147,000 | -36.4% | 556,665 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $231,000 | +22.9% | 556,665 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $188,000 | -53.1% | 556,665 | 0.0% | 0.00% | -66.7% |
| Q3 2019 | $401,000 | -1.0% | 556,665 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $405,000 | -40.1% | 556,665 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $676,000 | +192.6% | 556,665 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $231,000 | -79.2% | 556,665 | 0.0% | 0.00% | -71.4% |
| Q3 2018 | $1,113,000 | -5.7% | 556,665 | 0.0% | 0.01% | -22.2% |
| Q2 2018 | $1,180,000 | -22.1% | 556,665 | 0.0% | 0.01% | -30.8% |
| Q1 2018 | $1,514,000 | -44.7% | 556,665 | -24.9% | 0.01% | -45.8% |
| Q4 2017 | $2,737,000 | +90.2% | 741,665 | 0.0% | 0.02% | +100.0% |
| Q3 2017 | $1,439,000 | -28.1% | 741,665 | 0.0% | 0.01% | -33.3% |
| Q2 2017 | $2,002,000 | -34.2% | 741,665 | 0.0% | 0.02% | -28.0% |
| Q1 2017 | $3,041,000 | +13.3% | 741,665 | 0.0% | 0.02% | -3.8% |
| Q4 2016 | $2,685,000 | -17.2% | 741,665 | 0.0% | 0.03% | -10.3% |
| Q3 2016 | $3,241,000 | – | 741,665 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|